Tubot, Cristina C.
HRN: 23-46-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/13/2023
08/20/2023
IV
4.5g
Q8hrs
Infected Breast Mass
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamBone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes